We are live on
!
Find out more
LWCFA
Loring Wolcott & Coolidge Fiduciary Advisors Portfolio holdings
AUM
$10.3B
1-Year Est. Return
3.26%
This Fund
S&P 500
This Quarter
Est. Return
+1.22%
1 Year Est. Return
+3.26%
3 Year Est. Return
+43.63%
5 Year Est. Return
+56.22%
10 Year Est. Return
+342.64%
AUM
$11.6B
AUM Growth
+$425M
(+3.8%)
Cap. Flow
-$83.3M
Cap. Flow
% of AUM
-0.72%
Top 10 Holdings %
Top 10 Hldgs %
47.18%
Holding
586
New
15
Increased
41
Reduced
216
Closed
26
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Veeva Systems
VEEV
|
+$9.76M |
| 2 |
NVO
Novo Nordisk
NVO
|
+$8.82M |
| 3 |
NVIDIA
NVDA
|
+$8.78M |
| 4 |
Synopsys
SNPS
|
+$7.97M |
| 5 |
Dick's Sporting Goods
DKS
|
+$3.26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$10.2M |
| 2 |
Mastercard
MA
|
+$9.49M |
| 3 |
FISV
Fiserv Inc
FISV
|
+$7M |
| 4 |
Microsoft
MSFT
|
+$6.29M |
| 5 |
EOG Resources
EOG
|
+$5.55M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.56% |
| 2 | Healthcare | 16.29% |
| 3 | Consumer Discretionary | 11.3% |
| 4 | Financials | 10.86% |
| 5 | Communication Services | 8.03% |
Similar funds
ACA
GI
RA
RI
HRCM
HI
MF
MPI
Loring Wolcott & Coolidge Fiduciary Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Loring Wolcott & Coolidge Fiduciary Advisors held 586 positions worth $11.6B, up 3.8% from $11.2B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Loring Wolcott & Coolidge Fiduciary Advisors's Q4 2024 filing shows 15 new, 41 increased, 216 reduced and 26 closed positions. Its largest new stake was KKR & Co: 15,000 shares worth $2.42M. The largest sale was Cigna, an estimated $10.2M.
By sector, the portfolio is most concentrated in Technology at 39% of assets, down from 39% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Loring Wolcott & Coolidge Fiduciary Advisors's largest Q4 2024 buy was KKR & Co: 15,000 shares worth $2.42M.
- Loring Wolcott & Coolidge Fiduciary Advisors added most to Veeva Systems in Q4 2024, an estimated $9.76M increase.
- Loring Wolcott & Coolidge Fiduciary Advisors's biggest Q4 2024 reduction was Cigna, cutting an estimated $10.2M.
- Loring Wolcott & Coolidge Fiduciary Advisors fully exited iShares iBonds Dec 2024 Term Corporate ETF in Q4 2024, selling an estimated $151K.
- Loring Wolcott & Coolidge Fiduciary Advisors's ten largest holdings make up 47% of its $11.6B portfolio in Q4 2024.
- Loring Wolcott & Coolidge Fiduciary Advisors opened 15 new positions and closed 26 in Q4 2024.
- Loring Wolcott & Coolidge Fiduciary Advisors's portfolio value rose 3.8% quarter-over-quarter to $11.6B.
Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q4 2024, filed 28 Jan 2025.